Fluxion Biosciences expands its IonFlux automated patch clamp system

Fluxion Biosciences announced today a product expansion for its IonFlux automated patch clamp system which includes full automation and walk-away capability. New software drivers and hardware upgrades enable use of Tecan’s Freedom EVO® liquid handler series and accessories. This ensures automated plate preparation at a pace that fully optimizes the throughput of Fluxion’s ion channel screening platform.

“The high throughput capability of our IonFlux system makes manual pipetting impractical”

The IonFlux automated patch clamp system provides flexibility, time and cost savings compared with manual patch clamp rigs and first-generation automated electrophysiology systems. It is ideal for a wide range of ion channel screening applications and provides throughput up to 10,000 or more assays per day. The IonFlux system provides an extremely compact plate reader format making it ideal for liquid handler integration. The liquid handler capability is now a standard part of the IonFlux offering and existing systems can be upgraded. “The high throughput capability of our IonFlux system makes manual pipetting impractical,” explained Dr. Cristian Ionescu-Zanetti, Chief Technology Officer of Fluxion. “Automated liquid handling integration enables plate preparation to keep up with IonFlux system throughput, and allows full walk-away capability of up to four hours. Additionally, multiple IonFlux systems can be arrayed with a single liquid handler to increase throughput even more. While many of our customers are integrating the IonFlux system with liquid handlers they already have on site, this integration allows us to deliver a complete automation solution.”

With the Tecan component integration, the IonFlux system is now available with a wide range of options that can be tailored to the customer’s requirements. Available options include incubators, centrifuges for cell handling, dispensers and plate-grippers for liquid handling and plate transfer. Software integration between the two systems ensures simple, single-point control of the entire assay workflow.

Source: Fluxion Biosciences

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Fluxion Biosciences. (2010, January 27). Fluxion Biosciences expands its IonFlux automated patch clamp system. News-Medical. Retrieved on April 19, 2024 from https://www.news-medical.net/news/20100127/Fluxion-Biosciences-expands-its-IonFlux-automated-patch-clamp-system.aspx.

  • MLA

    Fluxion Biosciences. "Fluxion Biosciences expands its IonFlux automated patch clamp system". News-Medical. 19 April 2024. <https://www.news-medical.net/news/20100127/Fluxion-Biosciences-expands-its-IonFlux-automated-patch-clamp-system.aspx>.

  • Chicago

    Fluxion Biosciences. "Fluxion Biosciences expands its IonFlux automated patch clamp system". News-Medical. https://www.news-medical.net/news/20100127/Fluxion-Biosciences-expands-its-IonFlux-automated-patch-clamp-system.aspx. (accessed April 19, 2024).

  • Harvard

    Fluxion Biosciences. 2010. Fluxion Biosciences expands its IonFlux automated patch clamp system. News-Medical, viewed 19 April 2024, https://www.news-medical.net/news/20100127/Fluxion-Biosciences-expands-its-IonFlux-automated-patch-clamp-system.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Fluxion Biosciences reports first study results from early stage NSCLC patients